Minute Insight: Illumina Seeks Stability, Names Thaysen As New CEO

The genome-sequencing giant has named Jacob Thaysen, who brings extensive experience from Agilent, as its new leader.

Minute Insight
• Source: Citeline/Alamy

Illumina is trying to reduce the uncertainty surrounding its leadership and direction by naming a new CEO.

Jacob Thaysen, the current and president of Agilent Technologies’ life sciences and applied markets group, will take over...

More from Minute Insights

More from Medtech Insight